中医药导报2024,Vol.30Issue(4) :151-154.DOI:10.13862/j.cn43-1446/r.2024.04.028

基于辨机论治分析类风湿关节炎相关肺间质病变的诊治

Analysis of Diagnosis and Treatment of Rheumatoid Arthritis-Interstitial Lung Disease Based on Mechanism Differentiation and Treatment

马玉草 吕柳 黄正慧 郑晓佳 方锦颖 刘明煊 王艺文 王海隆
中医药导报2024,Vol.30Issue(4) :151-154.DOI:10.13862/j.cn43-1446/r.2024.04.028

基于辨机论治分析类风湿关节炎相关肺间质病变的诊治

Analysis of Diagnosis and Treatment of Rheumatoid Arthritis-Interstitial Lung Disease Based on Mechanism Differentiation and Treatment

马玉草 1吕柳 1黄正慧 1郑晓佳 1方锦颖 1刘明煊 1王艺文 1王海隆1
扫码查看

作者信息

  • 1. 北京中医药大学东直门医院,北京 100700
  • 折叠

摘要

基于辨机论治分析类风湿关节炎相关肺间质病变,认为该病属于"肺痹"范畴,可分为三期.肺痹早期病机为外邪侵袭;中期病机为肺气虚损,肝木不疏,痰瘀互结;晚期病机为肺肾亏虚,毒损肺络;同时药毒病机贯穿疾病始终.治疗方面,早期当因势利导,宣肺散邪;中期当补益肺气,疏理肝气,化痰逐瘀;晚期当补益肺肾,解毒通络,同时应尽量控制药毒损害.

Abstract

This article analyzed the rheumatoid arthritis-interstitial lung disease(RA-ILD)based on the mechanism differentiation and treatment.It is considered that the disease belongs to the category of"Fei Bi"and can be divided into three stages.The early pathogenesis of Fei Bi was the invasion of external pathogens,the middle pathogenesis was lung Qi deficiency,unsmooth of liver Qi and phlegm and blood stasis,and the late pathogenesis was lung and kidney deficiency and toxic damage to lung collaterals.At the same time,drug toxicity pathogenesis runs through the disease.In terms of treatment,early treatment was to dispele pathogens as soon as possible,disperse lung and eliminate pathogens,and middle treatment was to replenish and restore pulmonary Qi,regulate and soothe liver Qi,resolve phlegm and remove blood stasis,and late treatment was to replenish lung and kidney,detoxify and dredge collaterals,and pharmaco toxic damage should also be controlled as much as possible.

关键词

类风湿关节炎相关肺间质病变/类风湿关节炎/肺痹/辨机论治/病机/中医治疗

Key words

rheumatoid arthritis-interstitial lung disease/rheumatoid arthritis/Fei Bi/mechanism differ-entiation and treatment/pathogenesis/traditional Chinese medicine treatment

引用本文复制引用

基金项目

国家自然科学基金面上项目(82174336)

国家自然科学基金青年基金(82104652)

出版年

2024
中医药导报
湖南省中医药学会 湖南省中医管理局

中医药导报

CSTPCD
影响因子:0.952
ISSN:1672-951X
参考文献量28
段落导航相关论文